We Operate Exclusive High-Performance
International Clinical Trial Investigative Sites
CLINICAL TRIAL INVESTIGATIVE SITES
The DELTA HEALTH GROUP operates its own global network of dedicated and strategically located clinical trial investigative sites based on the maxim.....EXPERIENCE.....INTEGRITY....QUALITY.
We have long-term exclusivity agreements with globally located prominent teaching hospitals and clinics to operate and manage state-of-the-art clinical investigative sites having extensive experience in conducting drug development clinical trials according to ICH Good Clinical Practice Guidelines.
A number of these high-performance international investigative sites covering a multi-ethnic catchment area population of 10 million plus, have preferred access to a fast growing, highly compliant local clinical trial subject populace.
Independently audited and qualified, a number of these clinical facilities are recipients of the prestigious "Best Clinical Trial Site" recognition. These international investigative sites, primarily focused on conducting Phase 1, Phase 2 and Phase 3 drug development clinical trials have very low screen-failure and excellent patient retention rates. These clinical facilities are directly operated and managed by the DELTA HEALTH team members who have in-depth knowledge and hands-on experience in the management of successful North American clinical trial investigative sites.